Further Warning on French Health Costs

17 July 1994

France's Social Affairs Minister, Simone Veil, has warned the medical profession that despite lower spending in all sectors of the health service, if medical treatment costs are not cut as a result of the latest national agreement with doctors, "alternative scenarios will be brought into play."

Spending by the major health fund, the CNAMTS, stagnated in March, rose 0.2% in April and fell 0.8% in May, thus confirming the deceleration in spending growth reported since the start of the year.

CNAMTS analysts say the slowdown is due for the first time to a simultaneous decline in both hospital and non-hospital sector spending. Spending on fees fell 0.8% in May and drug spending was down 1%. the fund says the trend curve is bending the right way and that the 3.4% spending growth target for general medical care in 1994 is likely to be achieved.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight